Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	157.49B
Revenue (ttm)	17.31B
Net Income (ttm)	1.70B
Shares Out	208.49M
EPS (ttm)	8.61
PE Ratio	87.74
Forward PE	69.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	614,620
Average Volume	483,549
Open	763.90
Previous Close	757.85
Day's Range	745.85 - 769.75
52-Week Range	636.10 - 808.80
Beta	n/a
RSI	59.73
Earnings Date	May 14, 2025

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company offers medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Commercial Physical and Biological Research
• Founded: 1999
• Employees: 2,845
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In 2024, Sai Life Sciences's revenue was 17.31 billion, an increase of 18.17% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.